{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:58:17Z","timestamp":1792666697404,"version":"4.5.0"},"reference-count":186,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2019.00202","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T04:27:41Z","timestamp":1568348861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":160,"title":["Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis\u2014Literature Review"],"prefix":"10.3389","volume":"6","author":[{"given":"Abdulrahman","family":"Ismaiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan L.","family":"Dumitra\u015fcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"Heart disease and stroke statistics\u22122014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B6","unstructured":"Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients25560\n            RaduC\n            GrigorescuM\n            CrisanD\n            LupsorM\n            ConstantinD\n            DinaL\n          18836616J Gastrointestin Liver Dis.172008"},{"key":"B7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"Soderberg","year":"2010","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/MOL.0b013e32833c1f41","article-title":"Effects of ethanol intake on lipoproteins and atherosclerosis","volume":"21","author":"Brinton","year":"2010","journal-title":"Curr Opin Lipidol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.15403\/jgld.2014.1121.274.quo","article-title":"Nonalcoholic fatty liver disease: status quo","volume":"27","author":"Sporea","year":"2018","journal-title":"J Gastrointestin Liver Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.15386\/cjmed-993","article-title":"Non-alcoholic fatty liver disease: an update on diagnosis","volume":"91","author":"Dumitrascu","year":"2018","journal-title":"Clujul Med."},{"key":"B13","unstructured":"Psychological factors associated with NAFLD\/NASH: a systematic review508197\n            MacaveiB\n            BabanA\n            DumitrascuDL\n          28051263Eur Rev Med Pharmacol Sci.202016"},{"key":"B14","first-page":"2476","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"9","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin Liver Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver","volume":"67","author":"Chalasani","year":"2018","journal-title":"Diseases"},{"key":"B17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14797\/mdcj-8-3-21","article-title":"Fatty liver: a link to cardiovascular disease\u2013its natural history, pathogenesis, and treatment","volume":"8","author":"Monsour","year":"2012","journal-title":"Methodist Debakey Cardiovasc J."},{"key":"B18","first-page":"1179","article-title":"Pathology of alcoholic liver disease","volume-title":"Oxford Textbook of Clinical Hepatology","author":"Burt Ad","year":"1999"},{"key":"B19","unstructured":"Alcoholic liver disease11111151\n            Karl SeitzH.\n            MuellerS.\n            DancygierH\n          10.1007\/978-3-642-04519-6_34Berlin; HeidelbergSpringerClinical Hepatology: Principles and Practice of Hepatobiliary Diseases2010"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/circulationaha.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2097435","DOI":"10.1155\/2018\/2097435","article-title":"Nonalcoholic fatty liver disease","volume":"2018","author":"Filipovi\u0107","year":"2018","journal-title":"Can J Gastroenterol Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/MEG.0b013e32835a58b1","article-title":"Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease","volume":"25","author":"Kucukazman","year":"2013","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"Gastaldelli","year":"2009","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-277X.2005.00634.x","article-title":"Body mass index and waist circumference in non-alcoholic fatty liver disease","volume":"18","author":"Rocha","year":"2005","journal-title":"J Hum Nutr Diet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"124958","DOI":"10.1155\/2013\/124958","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis","volume":"2013","author":"Lu","year":"2013","journal-title":"Int J Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2123e2132","DOI":"10.2337\/dc09-0227","article-title":"Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis","volume":"32","author":"Baliunas","year":"2009","journal-title":"Diabet Care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00204-016-1770-3","article-title":"Carcinogenic compounds in alcoholic beverages: an update","volume":"90","author":"Pflaum","year":"2016","journal-title":"Arch Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1212\/WNL.0000000000003952","article-title":"Alcohol use and risk of intracerebral hemorrhage","volume":"88","author":"Chen","year":"2017","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1212\/wnl.0000000000005814","article-title":"Alcohol intake and the risk of intracerebral hemorrhage in the elderly","volume":"91","author":"Costa","year":"2018","journal-title":"MUCH-Italy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0035-1562947","article-title":"The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2","volume":"35","author":"Anstee","year":"2015","journal-title":"Semin Liver Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.gastro.2015.01.038","article-title":"TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?","volume":"148","author":"Kahali","year":"2015","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","article-title":"Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?","volume":"33","author":"Bhatia","year":"2012","journal-title":"Eur Heart J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol."},{"key":"B39","unstructured":"Is NAFLD an independent risk factor for increased IMT in T2DM?18793\n            CakirE\n            OzbekM\n            ColakN\n            CakalE\n            Deliba\u015fiT\n          22691891Minerva Endocrinol.372012"},{"key":"B40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/HCO.0b013e328354829c","article-title":"Nonalcoholic fatty liver disease and vascular risk","volume":"27","author":"Bhatia","year":"2012","journal-title":"Curr. Opin. Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"B44","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation"},{"key":"B45","first-page":"692","article-title":"Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome","volume":"116","author":"Hurjui","year":"2012","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12020-012-9712-1","article-title":"Assessment of endothelial function in patients with nonalcoholic fatty liver disease","volume":"43","author":"Colak","year":"2013","journal-title":"Endocrine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2013.01.013","article-title":"Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease","volume":"227","author":"Feitosa","year":"2013","journal-title":"Atherosclerosis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","article-title":"Adipokines in nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"B49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5507\/bp.2017.002","article-title":"Adipokines and cardiovascular disease: a comprehensive review","volume":"161","author":"Smekal","year":"2017","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech. Repub."},{"key":"B50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","article-title":"Ecological and evolutionary forces shaping microbial diversity in the human intestine","volume":"124","author":"Ley","year":"2006","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1194\/jlr.R800056-JLR200","article-title":"Emerging role of Toll-like receptors in atherosclerosis","volume":"50","author":"Curtiss","year":"2009","journal-title":"J Lipid Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"E1225","DOI":"10.3390\/ijms17081225","article-title":"The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease","volume":"17","author":"Sanduzzi Zamparelli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","article-title":"Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide","volume":"35","author":"Wang","year":"2014","journal-title":"Eur Heart J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1038\/ncomms10206","article-title":"Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese","volume":"6","author":"Tang","year":"2015","journal-title":"Nat Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000339344","article-title":"Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience","volume":"86","author":"Heuer","year":"2012","journal-title":"Digestion"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/s0140-6736(87)91605-9","article-title":"Central obesity and coronary heart disease in men","volume":"1","author":"Donahue","year":"1987","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1172\/jci29024","article-title":"Insulin resistance and atherosclerosis","volume":"116","author":"Semenkovich","year":"2006","journal-title":"J Clin Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/atvbaha.107.159228","article-title":"Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk","volume":"28","author":"Despres","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1478-3231.2011.02753.x","article-title":"Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease","volume":"32","author":"Treeprasertsuk","year":"2012","journal-title":"Liver Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jacl.2012.04.079","article-title":"Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction","volume":"7","author":"Blackett","year":"2013","journal-title":"J Clin Lipidol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jcmg.2009.12.013","article-title":"Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events","volume":"3","author":"Cheng","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1161\/circulationaha.106.678375","article-title":"To drink or not to drink? That is the question","volume":"116","author":"Kloner","year":"2007","journal-title":"Circulation"},{"key":"B66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/alcalc\/agp092","article-title":"Alcohol intake and systemic markers of inflammation\u2013shape of the association according to sex and body mass index","volume":"45","author":"Oliveira","year":"2010","journal-title":"Alcohol Alcohol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jcmg.2009.03.009","article-title":"Absence of coronary artery calcification and all-cause mortality","volume":"2","author":"Blaha","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"B68","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jcmg.2008.12.031","article-title":"Diagnostic and prognostic value of absence of coronary artery calcification","volume":"2","author":"Sarwar","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study","volume":"68","author":"Chang","year":"2018","journal-title":"Gut."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/gme.0000000000000503","article-title":"Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women","volume":"22","author":"Kim","year":"2015","journal-title":"Menopause"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/ehjci\/jew174","article-title":"Liver fat is related to cardiovascular risk factors and subclinical vascular disease: the Rotterdam Study","volume":"17","author":"Wolff","year":"2016","journal-title":"Eur Heart J-Card Img."},{"key":"B72","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jacl.2016.01.008","article-title":"Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: from the CAESAR study","volume":"10","author":"Kim","year":"2016","journal-title":"J Clin Lipidol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cgh.2016.01.010","article-title":"Association of nonalcoholic fatty liver disease with visceral adiposity but not coronary artery calcification in the elderly","volume":"14","author":"Jacobs","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-015-0253-9","article-title":"Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study","volume":"14","author":"Lee","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.atherosclerosis.2014.05.962","article-title":"Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the coronary artery risk development in young adults study","volume":"235","author":"Vanwagner","year":"2014","journal-title":"Atherosclerosis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1515\/cclm.2010.349","article-title":"Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification","volume":"48","author":"Jung","year":"2010","journal-title":"Clin Chem Lab Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MCA.0b013e3282583c0d","article-title":"Association between nonalcoholic fatty liver disease and coronary artery disease","volume":"18","author":"Arslan","year":"2007","journal-title":"Coron Artery Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1478-3231.2007.01531.x","article-title":"Liver: an alarm for the heart?","volume":"27","author":"Mirbagheri","year":"2007","journal-title":"Liver Int."},{"key":"B79","unstructured":"Evaluation of ultrasonographic fatty liver and severity of coronary atheroscledrosis, and obesity in patients undergoing coronary angiography27379\n            AcikelM\n            SunayS\n            KoplayM\n            GundogduF\n            KarakelleogluS\n          19666428Anadolu Kardiyol Derg.92009"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/jgh.12992","article-title":"Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification","volume":"30","author":"You","year":"2015","journal-title":"J Gastroenterol Hepatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3810\/pgm.2010.01.2091","article-title":"Carotid intima-media thickness: knowledge and application to everyday practice","volume":"122","author":"Cobble","year":"2010","journal-title":"Postgrad Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/nejm199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group","volume":"340","author":"O'leary","year":"1999","journal-title":"N Engl J Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/circulationaha.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"B84","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review","volume":"49","author":"Sookoian","year":"2008","journal-title":"J Hepatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12291-012-0286-8","article-title":"A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease","volume":"28","author":"Mishra","year":"2013","journal-title":"Indian J Clin Biochem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5830\/cvja-2016-014","article-title":"Gender-based differences in the relationship between fatty liver disease and atherosclerosis","volume":"27","author":"Kim","year":"2016","journal-title":"Cardiovasc J Afr."},{"key":"B88","unstructured":"Association of fatty liver with cardiovascular risk factors and subclinical atherosclerosis in a Mexican population40714\n            Martinez-Alvarado MdelR\n            Juarez-RojasJG\n            Medina-UrrutiaAX\n            Cardoso-SaldanaGC\n            Gonzalez-Salazar MdelC\n            Posadas-SanchezR\n          25695383Rev Invest Clin.662014"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1097\/hjh.0000000000001285","article-title":"Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease","volume":"35","author":"Li","year":"2017","journal-title":"J Hypertens."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1210\/jc.2009-0541","article-title":"Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients","volume":"94","author":"Petit","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B91","first-page":"55","article-title":"Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis","volume":"7","author":"Nahandi","year":"2014","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2337\/dc06-0135","article-title":"Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease","volume":"29","author":"Targher","year":"2006","journal-title":"Diabetes Care"},{"key":"B93","first-page":"251","article-title":"Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding","volume":"5","author":"Mohammadi","year":"2012","journal-title":"Int J Clin Exp Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2015.12.028","article-title":"Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression","volume":"246","author":"Bhatia","year":"2016","journal-title":"Atherosclerosis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.2337\/diacare.27.10.2498","article-title":"Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men. role of visceral fat accumulation","volume":"27","author":"Targher","year":"2004","journal-title":"Diabetes Care"},{"key":"B96","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/03009734.2013.814734","article-title":"Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis","volume":"118","author":"Arinc","year":"2013","journal-title":"UPS J Med Sci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1111\/j.1572-0241.2008.02188.x","article-title":"Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study","volume":"103","author":"Mckimmie","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000326854","article-title":"Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients","volume":"84","author":"Kim","year":"2011","journal-title":"Digestion"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e1087","DOI":"10.1097\/MD.0000000000001087","article-title":"Causes of thickening of carotid intima-media thickness in patients with alcoholic liver disease: a prospective observational study","volume":"94","author":"Qu","year":"2015","journal-title":"Medicine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"43059","DOI":"10.1038\/srep43059","article-title":"The correlation and risk factors between carotid intima-media thickening and alcoholic liver disease coupled with helicobacter pylori infection","volume":"7","author":"Bao-Ge","year":"2017","journal-title":"Sci Rep."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.4254\/wjh.v7.i10.1369","article-title":"Non-alcoholic fatty liver disease - the heart of the matter","volume":"7","author":"Azzam","year":"2015","journal-title":"World J Hepatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"J Hepatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2010.01.049","article-title":"Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis","volume":"211","author":"Yilmaz","year":"2010","journal-title":"Atherosclerosis"},{"key":"B104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/echo.14229","article-title":"Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation","volume":"36","author":"Mahfouz","year":"2019","journal-title":"Echocardiography"},{"key":"B105","doi-asserted-by":"publisher","first-page":"974","DOI":"10.14744\/AnatolJCardiol.2016.6706","article-title":"Aortic flow propagation velocity, epicardial fat thickness, and osteoprotegerin level to predict subclinical atherosclerosis in patients with nonalcoholic fatty liver disease","volume":"16","author":"Oguz","year":"2016","journal-title":"Anatol J Cardiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.numecd.2015.10.013","article-title":"Subclinical atherosclerosis is associated with epicardial fat thickness and hepatic steatosis in the general population","volume":"26","author":"Baragetti","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2014.10.004","article-title":"Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness","volume":"237","author":"Sunbul","year":"2014","journal-title":"Atherosclerosis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0003319715576672","article-title":"Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function","volume":"67","author":"Psychari","year":"2016","journal-title":"Angiology"},{"key":"B109","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/00365529609004879","article-title":"Left ventricular diastolic function in liver cirrhosis","volume":"31","author":"Finucci","year":"1996","journal-title":"Scand J Gastroenterol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/postgradmedj-2015-133755","article-title":"Cardiac manifestations in alcoholic liver disease","volume":"92","author":"Mili\u0107","year":"2016","journal-title":"Postgrad Med J."},{"key":"B111","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2009.10.030","article-title":"Heart valve sclerosis predicts all-cause and cardiovascular mortality","volume":"209","author":"Volzke","year":"2010","journal-title":"Atherosclerosis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis\u2013from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N Engl J Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1161\/atvbaha.112.300556","article-title":"Hepatic steatosis is associated with aortic valve sclerosis in the general population: the Study of Health in Pomerania (SHIP)","volume":"33","author":"Markus","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e88371","DOI":"10.1371\/journal.pone.0088371","article-title":"Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus","volume":"9","author":"Bonapace","year":"2014","journal-title":"PLoS ONE"},{"key":"B116","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.metabol.2015.04.003","article-title":"Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"64","author":"Mantovani","year":"2015","journal-title":"Metabolism"},{"key":"B117","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/liv.14044","article-title":"Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis","volume":"39","author":"Mantovani","year":"2019","journal-title":"Liver Int"},{"key":"B118","doi-asserted-by":"publisher","first-page":"5628749","DOI":"10.1155\/2018\/5628749","article-title":"Nonalcoholic fatty liver disease is associated with increased atrial fibrillation risk in an elderly chinese population: a cross-sectional study","volume":"2018","author":"Zhang","year":"2018"},{"key":"B119","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2015.12.023","article-title":"Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP)","volume":"245","author":"Markus","year":"2016","journal-title":"Atherosclerosis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.dld.2018.02.002","article-title":"NAFLD and risk of cardiac arrhythmias: is hyperuricemia a neglected pathogenic mechanism?","volume":"50","author":"Mantovani","year":"2018","journal-title":"Dig Liver Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2337\/dc16-0091","article-title":"Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour holter monitoring","volume":"39","author":"Mantovani","year":"2016","journal-title":"Diabetes Care"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.001820","article-title":"Nonalcoholic fatty liver disease is associated with qt prolongation in the general population","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e0185459","DOI":"10.1371\/journal.pone.0185459","article-title":"Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus","volume":"12","author":"Mantovani","year":"2017","journal-title":"PLoS ONE."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.ijcard.2013.07.035","article-title":"RBBB is associated with an increased risk of NAFLD in young healthy individuals","volume":"168","author":"Iscen","year":"2013","journal-title":"Int J Cardiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.12659\/msm.890741","article-title":"Deterioration of heart rate recovery index in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"20","author":"Ozveren","year":"2014","journal-title":"Med Sci Monit."},{"key":"B126","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/flgastro-2013-100404","article-title":"Non-alcoholic fatty liver disease: a practical approach to treatment","volume":"5","author":"Dyson","year":"2014","journal-title":"Front Gastroenterol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1073\/pnas.0308291101","article-title":"Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans","volume":"101","author":"Fontana","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B128","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology."},{"key":"B129","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/ajcn\/86.2.285","article-title":"Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease","volume":"86","author":"Zivkovic","year":"2007","journal-title":"Am J Clin Nutr."},{"key":"B130","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J Hepatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/apt.13523","article-title":"Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis","volume":"43","author":"Kennedy","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total body weight loss of >\/= 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis","volume":"60","author":"Glass","year":"2015","journal-title":"Dig Dis Sci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.amjcard.2011.06.076","article-title":"Effect of bariatric surgery on cardiovascular risk profile","volume":"108","author":"Heneghan","year":"2011","journal-title":"Am J Cardiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tcm.2014.09.005","article-title":"Impact of obesity on cardiac metabolism, fibrosis, and function","volume":"25","author":"Mahajan","year":"2015","journal-title":"Trends Cardiovasc Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/dmso.s124541","article-title":"Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity","volume":"10","author":"Karimian","year":"2017","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.ahj.2005.02.004","article-title":"Obesity as a prognostic factor in chronic symptomatic heart failure","volume":"150","author":"Bozkurt","year":"2005","journal-title":"Am Heart J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cjca.2014.08.004","article-title":"Obesity and the obesity paradox in heart failure","volume":"31","author":"Gupta","year":"2015","journal-title":"Can J Cardiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjcard.2014.09.044","article-title":"Relation of physical activity to prevalence of nonalcoholic fatty liver disease independent of cardiometabolic risk","volume":"115","author":"Oni","year":"2015","journal-title":"Am J Cardiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.1152\/ajpendo.00210.2009","article-title":"Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus","volume":"297","author":"Kirwan","year":"2009","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1249\/MSS.0b013e3181df16d9","article-title":"Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth","volume":"42","author":"Van Der Heijden","year":"2010","journal-title":"Med Sci Sports Exerc."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jamainternmed.2016.3202","article-title":"Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: a randomized clinical trialeffects of exercise on nonalcoholic fatty liver diseaseeffects of exercise on nonalcoholic fatty liver disease","volume":"176","author":"Zhang","year":"2016","journal-title":"JAMA Int Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cgh.2016.04.036","article-title":"Exercise-based Interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression","volume":"14","author":"Orci","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"68","DOI":"10.7326\/m14-0130","article-title":"Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: a systematic review for the U. S. Preventive Services Task Force","volume":"161","author":"Lin","year":"2014","journal-title":"Ann Intern Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1042\/cs20150308","article-title":"Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"129","author":"Hallsworth","year":"2015","journal-title":"Clin Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/liv.13311","article-title":"Non-pharmacological interventions in non-alcoholic fatty liver disease patients","volume":"37","author":"Ratziu","year":"2017","journal-title":"Liver Int."},{"key":"B150","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J Hepatol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysisassociation of aspirin use for primary prevention of CVD with cardiovascular events and bleedingassociation of aspirin use for primary prevention of CVD with cardiovascular events and bleeding","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"key":"B152","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/apt.13515","article-title":"Aspirin use is associated with lower indices of liver fibrosis among adults in the United States","volume":"43","author":"Jiang","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.04.061","article-title":"Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease","author":"Simon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3748\/wjg.15.942","article-title":"Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis","volume":"15","author":"Georgescu","year":"2009","journal-title":"World J Gastroenterol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"B157","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrneph.2017.16","article-title":"Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease","volume":"13","author":"Targher","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e0163069","DOI":"10.1371\/journal.pone.0163069","article-title":"Renin-angiotensin system inhibitors, Type 2 diabetes and fibrosis progression: an observational study in patients with nonalcoholic fatty liver disease","volume":"11","author":"Pelusi","year":"2016","journal-title":"PLoS ONE"},{"key":"B159","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med."},{"key":"B160","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.dld.2014.04.002","article-title":"Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals","volume":"46","author":"De Keyser","year":"2014","journal-title":"Dig Liver Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.arcmed.2013.12.003","article-title":"Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease","volume":"45","author":"Oni","year":"2014","journal-title":"Arch Med Res."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004816.pub4","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"B163","doi-asserted-by":"publisher","first-page":"g4379","DOI":"10.1136\/bmj.g4379","article-title":"Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients","volume":"349","author":"Keene","year":"2014","journal-title":"BMJ Br Med J."},{"key":"B164","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1016\/j.ijcard.2013.06.024","article-title":"Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels","volume":"168","author":"Tikkanen","year":"2013","journal-title":"Int J Cardiol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11886-013-0397-8","article-title":"Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy","volume":"15","author":"Wiklund","year":"2013","journal-title":"Curr Cardiol Rep."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek atorvastatin and coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J."},{"key":"B168","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology."},{"key":"B169","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"Argo","year":"2015","journal-title":"J Hepatol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2016\/1459790","article-title":"Effects of Omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis","volume":"2016","author":"Lu","year":"2016","journal-title":"Gastroenterol Res Pract."},{"key":"B171","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed Rep"},{"key":"B172","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/ajg.2013.5","article-title":"Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4254\/wjh.v7.i12.1652","article-title":"Systematic review: preventive and therapeutic applications of metformin in liver disease","volume":"7","author":"Bhat","year":"2015","journal-title":"World J Hepatol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2337\/db18-167-OR","article-title":"Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus\u2014The MET-REMODEL trial","volume":"67","author":"Mohan","year":"2018","journal-title":"Diabetes"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"305","DOI":"10.7326\/m15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med."},{"key":"B177","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/s0140-6736(15)00803-x","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.2016-2775","article-title":"Effect of liraglutide therapy on liver fat content in patients with inadequately controlled Type 2 diabetes: the Lira-NAFLD Study","volume":"102","author":"Petit","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B180","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.diabet.2019.01.008","article-title":"Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: a common comorbidity associated with severe complications","volume":"45","author":"Scheen","year":"2019","journal-title":"Diabetes Metab."},{"key":"B182","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jhep.2016.04.021","article-title":"Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"65","author":"Cui","year":"2016","journal-title":"J Hepatol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator\u2013activated receptor\u2013\u03b1 and \u2013\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology."},{"key":"B184","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/liv.13270","article-title":"The therapeutic landscape of non-alcoholic steatohepatitis","volume":"37","author":"Perazzo","year":"2017","journal-title":"Liver Int."},{"key":"B185","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B186","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11605-014-2678-y","article-title":"Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis","volume":"19","author":"Taitano","year":"2015","journal-title":"J Gastrointest Surg."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00202\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T13:51:36Z","timestamp":1568814696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00202\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":186,"alternative-id":["10.3389\/fmed.2019.00202"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2019.00202","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"article-number":"202"}}